Ignite Creation Date:
2024-05-06 @ 7:11 AM
Last Modification Date:
2024-10-26 @ 11:45 AM
Study NCT ID:
NCT02489448
Status:
COMPLETED
Last Update Posted:
2022-10-26
First Post:
2015-07-01
Brief Title:
Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer
Sponsor:
Yale University
Organization:
Yale University
Organization Data
Organization:
Yale University
Class:
OTHER
Study ID:
1409014537
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yale University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None